Mode
Text Size
Log in / Sign up
N/A N=34 Health Services Research

Pilot Study of B-Type Natrieutic Peptide (BNP) Levels in Patients With Congenital Heart Disease(BNP)

Congenital Heart Disease · Cardiovascular Disease

Enrolled (actual)
34
Serious AEs
0.0%
Results posted
Jul 2014
Primary outcome: Primary: BNP Levels — 16.3; 42.4; 384.3 pg/ml

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Six minute walk test (Procedure); Minnesota Living with Heart Failure Questionnaire (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Emory University
Primary completion
Mar 2004

Outcome Measures

OutcomeResultp-value
PRIMARY
BNP Levels
16.3; 42.4; 384.3

Summary

The object of this study is to measure the levels of B-type Natriuretic Peptide (BNP) in patients with congenital heart disease, normal individuals, and patients with acquired heart failure, and compare the results from each group.

Eligibility Criteria

Inclusion Criteria:Patients with a systemic right ventricle and a subpulmonic left ventricle-including patients with transposition of the great arteries (d-TGA) who have undergone Mustard and Senning repairs (atrial switch procedures) and patients with congenitally corrected TGA (l-TGA) Subpulmonic right ventricle in the absence of pulmonary hypertension (repaired tetralogy of Fallot, congenital pulmonic regurgitation) 4-chambered heart Age > 18 years Participants will have either acquired left ventricular dysfunction (ejection fraction 4.0 Significant pulmonary hypertension (systolic PAP >60 mmHg by Echo) Uncontrolled systemic arterial hypertension (systolic > 200 mmHg or diastolic >105 mmHg) Myocardial infarction or acute coronary syndrome within 2 months D-TGA status post atrial switch procedure (Jatene) Intracardiac shunts Inadequate echocardiogram windows Coronary Angioplasty 30 days
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00308230). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search